Evidence map›Paper›PMID 41810285›Full record

ArticleFrontiers in public health2026

Data generation and modeling during COVID-19: utility, barriers, and priorities for future investments in public health response.

Kristen Nixon, Shaun Truelove, Lauren Gardner

Abstract read
In one paragraph

Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Kristen NixonDepartment of Civil and Systems Engineering, Johns Hopkins University, Baltimore, MD, United States.
Shaun TrueloveDepartment of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.
Lauren GardnerDepartment of Civil and Systems Engineering, Johns Hopkins University, Baltimore, MD, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

During the COVID-19 pandemic, policymakers and business leaders had to rapidly make consequential decisions, and researchers rushed to provide useful information, making use of data, infectious disease models, and public health knowledge. Our study surveyed 112 individuals engaged in COVID-19 response in the US, including data collectors, modelers, and users of these tools to determine how useful different data-driven tools were for informing response work, the most impactful challenges, and the most promising opportunities for future investment. Respondents overwhelmingly found data, models, and collaborations with researchers to be useful. The most impactful challenges, and also the most promising areas for future investment, were in data availability and quality. Respondents wanted higher quality data, more granular data, and access to a variety of data types. The second most influential challenge was insufficient human resources, with public health institutions being particularly under-resourced. Academics also played a valuable role, despite incentives that often conflict with real-time response work. Our survey results also highlight the importance and challenges of translational work, including shortcomings in science communication and difficulty navigating political influences. This study provides concrete evidence of the value of data and modeling tools for epidemic response and outlines priorities for future investment.

Indexed as

COVID-19Data CollectionPublic HealthHumansPandemicsSARS-CoV-2Surveys and QuestionnairesUnited StatesCOVID-19datadecision-makingepidemiologyinfectious diseasemathematical modeling

Identifiers

PMID41810285
PMCPMC12968176

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.